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The fungus Aspergillus niger is a main source of industrial
cellulase. -1,4-Endoglucanase is the major component of
cellulase from A. niger. In spite of widespread applications,
little is known about the structure of this enzyme. Here, the
structure of -1,4-endoglucanase from A. niger (EglA) was
determined at 2.1 AÊ resolution. Although there is a low
sequence identity between EglA and CelB2, another member
of family 12, the three-dimensional structures of their core
regions are quite similar. The structural differences are mostly
found in the loop regions, where CelB2 has an extra -sheet
(-sheet C) at the non-reducing end of the binding cleft of the
native enzyme. Incubation of EglA with PdCl2 irreversibly
inhibits the EglA activity. Structural studies of the enzyme±
palladium complex show that three Pd2+ ions bind to each
EglA molecule. One of the Pd2+ ions forms a coordinate
covalent bond with Met118 S and the nucleophilic
Glu116 O"1 at the active site of the enzyme. The other two
Pd2+ ions bind on the surface of the protein. Binding of Pd2+
ions to EglA does not change the general conformation of the
backbone of the protein signi®cantly. Based on this structural
study, one can conclude that the palladium ion directly binds
to and blocks the active site of EglA and thus inactivates the
enzyme.
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1. Introduction
Cellulose is a linear polymer of glucosyl units connected by
-1,4 linkages. These linear chains vary in length and often
consist of many thousands of units. Much of the organic
material on the surface of the earth is stored in the form of
cellulose. There is an enormous turnover of cellulose within
the biosphere owing to large-scale production and degrada-
tion. Because of energy crises, cellulose is an important
alternative source of renewable energy (Bhat & Bhat, 1997;
Wyman, 1999; Lynd et al., 1999). Many bacteria and fungi have
developed mechanisms to break down this complex substrate,
utilizing multiple enzymes collectively called cellulases. Acting
together, these enzymes convert an insoluble polymer to its
monomer, glucose. Current commercial applications of cellu-
lases are mainly limited to the detergent and textile industries
(Schulein et al., 1998); however, present environmental
concerns have refueled interest in the application of cellulases
in biomass conversion (Sheehan & Himmel, 1999). For
instance, using cellulases in recycling and de-inking copier-
printed and laser-printed papers avoids the alkaline environ-
ment commonly required in traditional de-inking, conse-
quently cutting chemical processing cost and signi®cantly
reducing environmental contamination (Gubitz et al., 1998).
Aspergillus niger is an important
commercial source of inexpensive
cellulase, not only in the food and
textile industries but also in pharma-
ceutical industries (Bakalova et al.,
1996). Endo--1,4-glucanase is the main
component for cellulose degradation by
A. niger and has been assigned to
glycosyl hydrolase family 12 (Fig. 1). It
is known to catalyze glycosidic bond
cleavage with net retention of anomeric
con®guration (Henrissat & Bairoch,
1997; Zechel et al., 1998). Family 12
enzymes employ a stepwise catalytic
mechanism in which a glycosyl-enzyme
intermediate is formed and subse-
quently hydrolyzed via oxocarbenium-
ion transition states (Davies et al.,
1998). Analysis of hydrophobic clusters
shows a signi®cant similarity between
xylanases from family 11 and endoglu-
canases from family 12. Therefore,
these two families are considered as
clan GH-C (Torronen et al., 1993). In
1997, Sulzenbacher and coworkers
determined the structure of an endo--
1,4-glucanase from Streptomyces livi-
dans (CelB2), a member of glycoside
hydrolase family 12 (PDB entry 1nlr;
Sulzenbacher et al., 1997), and showed
that the structure of the core region of
CelB2 is very similar to that of family 11
enzymes and that the differences are in
the loop regions. Here, we describe the
three-dimensional structure of the
catalytic domain of A. niger endoglu-
canase (EglA) as an important member
of family 12.
Palladium complexes have been shown to inhibit certain
cellulases from various sources. For example, palladium
compounds irreversibly inhibit cellobiohydrolase I and
endoglucanase II, but not cellobiohydrolase II from Tricho-
derma reesei (Lassig et al., 1995; Shultz et al., 1995). Other
metals, such as platinum and rhodium, do not inhibit these
cellulases. The mode of inhibition of cellulases by palladium
complexes has been a subject for conjecture (Lassig et al.,
1995; Shultz et al., 1995). Here, we not only show the inhibition
of EglA by palladium chloride, but also describe the mode of
inhibition of EglA by palladium based on the structure of the
EglA±palladium complex.
2. Materials and methods
2.1. Cellulase purification
A. niger (strain CBS 554.65; ATCC 16888) was cultivated in
1 l culture ¯asks with 300 ml of Norkans medium modi®ed
after Eriksson & Pettersson (1975). As a carbon source, 10 g
of `Pro®x Cellulose Flies' were added to the medium. The
¯asks, inoculated with conidia of A. niger, were incubated for
18 d at 303 K. The culture solution was separated from
mycelium and cellulose by vacuum-®ltration funnels. The
extracted solution was concentrated 100-fold with a Minitan-
Tangential 10 kDa NMWL ®ltration system (Millipore). The
solution was subsequently ®ltered with a Millipore 0.45 mm
membrane ®lter, type HAWP.
The initial gel ®ltration was carried out with a 1000 
50 mm Sephacryl S200 HR column (Pharmacia) using a buffer
system of 0.05 M KH2PO4 pH 6.0 and 0.15 M NaCl. The
volume of the ®fth peak was concentrated and prepared by
buffer exchange for chromatofocusing performed with a 50 
10 mm column ®lled with Polybuffer Exchanger 9-4 (Phar-
macia). The starting buffer was 0.015 M 2-methylpiperazine
pH 5.0. The limit buffer was Servalyt 3±6 diluted to a
concentration of 0.2%(w/v), pH 3.1. The resultant enzyme
solution was further puri®ed by anion-exchange chromato-
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Figure 1
Multiple sequence alignment among catalytic domain sequence of glycosyl hydrolase family 12. The
conserved residues are in bold. The putative catalytic residues are marked by a star. The sequences
are as follows; S. lividance, Streptomyces lividans (U04629); S. rochei, Streptomyces rochei (X73953);
R. marinus, Rhodothermus marinus (U72637); A. kawachii, Aspergillus kawachii (Q12679);
A. niger, Aspergillus niger (AJ224452); A. oryzae, Aspergillus oryzae (D83731);
A. aculeatus, Aspergillus aculeatus (P22669); T. reesei, Trichoderma reesei (AB003694);
S. coelicolor, Streptomyces coelicolor (AL355913); E. carotovora, Erwinia carotovora (P16630).
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graphy, using a 100  20 mm column with DEAE Si 300
(Serva Novex). The protein was eluted by applying a gradient
from 10 to 100 mM KH2PO4 pH 7.4. The volume of the main
peak was concentrated with a CX 10 Millipore cartridge,
10 kDa NMWL, de-salted with Sephadex G25 (Pharmacia)
and ®nally lyophilized.
2.2. Enzyme assays
The endoglucanase activity of the NtEgl was measured by
incubating a solution of 1 mg mlÿ1 EglA with 1%(w/v) sodium
carboxymethyl cellulose [CMC; average molecular weight,
250 000 Da; degree of carboxymethyl substitution, 0.7(w/v);
Aldrich] in 50 mM sodium acetate pH 5.0 at 310 K for 30 min.
In order to determine the produced reducing sugar, 10 ml of
the reaction solution was added to 1 ml of tetrazolium blue
reagent solution (Jue & Lipke, 1985) and the mixture was then
boiled for 3 min. After cooling, absorbance was determined at
660 nm. In order to determine inhibition of EglA by PdCl2, a
solution of 1 mg mlÿ1 EglA was preincubated with 100 mM
PdCl2 for 15 min, after which the reaction was started by
addition of 1% CMC. Degradation of CMC was linear for at
least 60 min.
2.3. Crystallization and data collection
The hanging-drop vapor-diffusion method was used for
crystallization of EglA. On a cover slide, 3 ml of protein
solution (9 mg mlÿ1 EglA in buffer) and 3 ml of reservoir (28%
PEG 4K and 100 mM acetate pH 4.8) were mixed and equi-
librated against a 1 ml reservoir. During two weeks, the crystal
was transferred twice into fresh protein solution. The size of
crystal before it was transferred into fresh protein solution was
about 0.1  0.1  0.1 mm. The fresh protein solution was pre-
equilibrated with the buffer for about 30 min. After transfer-
ring into new protein solution, the crystal was equilibrated
against the new reservoir solution. After two or three weeks,
when the crystal size was 0.4  0.4  0.4 mm, the crystal was
harvested. The space group of the crystal is I422, with unit-cell
parameters a = b = 131.77, c = 71.72 AÊ ,  =  =  = 90.
Data collection was performed at room temperature using a
Nonius/MacScience DIP2030-k image plate and a Rigaku
rotating-anode X-ray source with Cu K radiation focused by
an MSC/Osmic mirror system. Diffraction data were evaluated
with DENZO and scaled using SCALEPACK (Otwinowski &
Minor, 1997) (Table 1).
2.4. Structure determination and refinement
Patterson search methods using the CNS package were used
to solve the phasing problem. We used the fast direct rotation-
search method (DeLano & BruÈ nger, 1995; BruÈ nger, 1997) with
the CNS package, using the complete CelB2 structure as the
search model. Sequence comparison between CelB2 and EglA
shows only 26% sequence identity (Fig. 1). Native EglA
diffraction data between d = 15 and 4.0 AÊ with Fobs > 2 were
used in a direct rotation-search method. The top ten peaks
from the rotation search were each subjected to 30 steps of
Patterson correlation (PC) re®nement (BruÈ nger, 1990) using a
target of squared normalized structure factors. A fast trans-
lation search (Navaza & Vernoslova, 1995) was carried out for
each of the top ten rotation-function peaks after PC re®ne-
ment. The highest translation-search peaks were further
improved by 30 steps of PC re®nement.
The re®nement was performed with the maximum-
likelihood method based on amplitudes (Pannu & Read,
1996). Only 90% of the data in the resolution range 30±2.1 AÊ
were used for the re®nement and the remaining 10% were
reserved throughout as the test set for structure validation
(F cutoff = 0). The best solution after rigid-body re®nement
had an R value of 52.5% (Rfree = 52.2%). Simulated annealing
using torsion-angle molecular dynamics employed a protocol
used by Adams et al. (1997), with initial minimization followed
by torsion-angle molecular dynamics and slow cooling from
5000 to 0 K in 50 K steps. This ®rst round of simulated-
annealing re®nement reduced the R value from 52.5 to 42.9%
(Rfree fell from 52.2 to 44.4%). At this point, the amino acids of
CelB2 were replaced manually with the corresponding resi-
dues from EglA based on multiple sequence alignment results
for family 12 enzymes (Fig. 1) using PRONTO (Laczkowski et
al., 1996).
Because of signi®cant differences in loop regions between
CelB2 and EglA, the core-tracing algorithm (Swanson, 1994)
greatly assisted with the assignment of backbone location in
initial approximately phased electron-density maps. The
re®nement proceeded with simulated annealing, which
corrected errors introduced by the manual rebuilding and
optimized the ®t of the retraced region. After many steps of
simulated-annealing re®nement and manual rebuilding
followed by re®nement of individual B factors, the R value was
reduced to 23.1% (Rfree to 24.8%). Addition of water mole-
cules to the model and ®nal re®nement reduced the R factor to
17.5% (Rfree to 19.6%).
Table 1
Structure determination summary for EglA.
Values for the highest resolution shells are in parentheses.
Native EglA
EglA±palladium
complex
Space group I422 I422
Unit-cell parameters
(AÊ , )
a = b = 131.57, c = 71.64,
 =  =  = 90.00
a = b = 131.09, c = 71.99,
 =  =  = 90.00
Resolution range (AÊ ) 30.0±2.1 (2.18±2.10) 30.0±2.5 (2.55±2.50)
Completeness (%) 98.0 (95.5) 96.0 (89.3)
Total re¯ections 325097 117527
Unique re¯ections 18660 11084
I/(I) 31.0 (6.9) 26.7 (3.7)
Rmerge² 0.07 (0.30) 0.09 (0.63)
No. of protein atoms 1717 1717
No. of water molecules 124 34
No. of Pd2+ ions Ð 3
R value³ (%) 17.5 20.8
Rfree (%) 19.6 24.2
R.m.d.s. bonds (AÊ ) 0.006 0.009
R.m.d.s. angles () 1.34 1.43
² Rmerge =
P
h
P
i jIhi ÿ hIhij=
P
h
P
ihIhii, where I is the observed intensity and hIi
is the average intensity of multiple observations of symmetry-related re¯ections. ³ R
value =
PjFoj ÿ jFcj=P jFoj.
The structure of the palladium±EglA complex was deter-
mined using the data collected from a crystal of EglA soaked
in 5 mM PdCl2 for 20 min. The ®nal model of the native EglA
was used as an initial model for the re®nement. After addition
of palladium ions and water molecules along with several steps
of simulated-annealing re®nement, the ®nal model with an R
factor of 21.4% (Rfree = 24.6%) was obtained (Table 1).
3. Results and discussion
3.1. Crystallography
The structure of EglA was determined by the Patterson
search method using the structure of native endoglucanase
from S. lividans (CelB2), with 26% identity with EglA, as a
search model. The ®nal structure contains one molecule per
asymmetric unit and 16 asymmetric units per cell in the space
group I422, with unit-cell parameters a = b = 131.77,
c = 71.72 AÊ ,  =  =  = 90 (Table 1). All 223 residues (1717
non-H protein atoms) and 124 water molecules are included in
the re®ned model. The ®nal crystallographic R value is 17.5%
and the ®nal Rfree is 19.6% for the resolution range 30.0±2.1 AÊ .
Using the program PROCHECK (Laskowski et al., 1993),
90% of the non-glycine residues have their backbone
conformational angles (’/ ) in the most favored regions of the
Ramachandran plot (Ramakrishnan & Ramachandran, 1965).
No residues fall into the disallowed regions.
A data set from a crystal soaked in 5 mM PdCl2 was used to
determine the structure of the palladium±EglA complex
(Table 1). The ®nal model consists of 223 residues, three Pd2+
ions and 34 water molecules. The structure was re®ned to a
®nal R factor of 20.8% (Rfree = 24.2%), including all re¯ections
between 30.0 and 2.5 AÊ (98.5% completeness). The overall
geometry is good (0.009 r.m.s.d. in bond lengths and 1.43 in
bond angles). The root-mean-square ®t between the C atoms
of native EglA and the palladium±EglA complex is 0.4 AÊ .
3.2. Molecular structure
The catalytic core of EglA is a single-domain polypeptide
chain with approximate dimensions of 40  40  35 AÊ . EglA
has a `jelly-roll' fold with two antiparallel -
sheets (outer A and inner B), which is a
common folding motif in endoglucanases
from family 12 (Fig. 2). -Sheet A contains
six strands (A1±A6) and -sheet B contains
nine strands (B1±B9). The hydrophilic face
of -sheet A is exposed to solvent. The
hydrophilic face of -sheet B forms a long
open cleft which is the binding site for
substrate.
One of the rims of the active-site cleft
consists of two loops between strands B5
and B6 and between strands B7 and B8.
Backbone atoms in the loop B7±B8 have
higher main-chain temperature factors
(40.3 AÊ 2 on average compared with 21.3 AÊ 2
for the average B factors of protein back-
bone atoms), suggesting that this loop is relatively ¯exible.
This loop may move inward upon binding of the substrate and
cover the binding site. Loops between strands B2 and A2 and
between strands B3 and A3 form a part of the other rim of the
active-site cleft.
There is a surface loop between -strands B6 and B9. This
loop, conserved in family 11 xylanases and family 12 endo-
glucanases, closes the substrate-binding cleft at its far end and
has been referred to as the `cord' (Torronen et al., 1994). The
residues in the cord region (Gly125, Asn126, Ile127, Gln128,
Pro129, Ile130 and Gly131) have a clear electron-density map,
indicating that the cord segment has a well de®ned structure.
In family 12, amino acids in the cord region are highly
conserved.
Two mostly conserved cysteine residues, Cys4 and Cys32,
form a disul®de bridge to stabilize the three-dimensional fold
of EglA by connecting strands A1 and A2. The structure
contains two cis-prolines, Pro14 and Pro210. Pro14 is located
in a turn between -strands B1 and B2 and Pro210 is located
between -strands B4 and A4. EglA contains 19 negatively
charged residues (aspartate and glutamate) and 11 positively
charged residues (lysine, arginine and histidine). There are
three salt bridges: between His46 and Asp36, between Arg123
and Glu145, and between Arg159 and Glu157. None of these
residues is conserved in family 12.
3.3. The active-site cleft
The active site is located in the cleft on the surface of
-sheet B as con®rmed by the Pd2+-binding site. The extent of
the cleft was estimated by calculating the solvent-accessible
surface, giving a length of 35 AÊ and a depth of 9 AÊ . The cleft is
9 AÊ wide for most of its extended length. The smallest width is
about 4 AÊ , between Trp22 and Gln153. This 35 AÊ long cleft is
likely to bind around six glucopyranose units, which can be
numbered from the non-reducing end (subsite ÿ3) to the
reducing end (subsite +3). The directionality of the cleft from
the non-reducing end to the reducing end was determined
based on comparison of this structure and the structure of the
2-¯uorocellotryiosyl complex of CelB2 (Sulzenbacher et al.,
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Figure 2
Ribbon stereo diagram of EglA. -sheet A is in blue, -sheet B is in green and helices are in
red.
research papers
664 Khademi et al.  Endoglucanase±palladium complex Acta Cryst. (2002). D58, 660±667
1999). The cleavage takes place, by de®nition, between
subsites ÿ1 and +1. An active site with a length of ®ve or six
glucopyranose units is consistent with the results of kinetics
assays that showed the products of hydrolysis of CMC to be
®ve or six glucopyranose units in length. The substrate-binding
cleft is lined with a number of aromatic residues that may bind
the hydrophobic faces of the pyranoside rings (Fig. 3).
By analyzing the conserved residues in the binding cleft and
by comparison of the structure of EglA with the structure of a
¯uorocellotriosyl±CelB2 complex (Sulzenbacher et al., 1999),
we can make tentative functional assignments for the residues
in the binding cleft (Fig. 3). At the non-reducing end of the
cleft, the side chain of Tyr7 would interact with the gluco-
pyranose ring in subsiteÿ3. Trp22 is invariant and would ¯ank
subsite ÿ2. Invariant residue Asn20 may interact with a
hydroxyl group in the glucopyranose rings at either the ÿ3 or
ÿ2 subsite. In subsite ÿ1, the conserved aromatic residues
Tyr61 and Phe101 may stabilize the hydrophobic gluco-
pyranose ring. In subsite ÿ1, stabilization would occur
through hydrogen bonding to the acid/base Glu204 and to
residues Glu158 and Trp22. The invariant Met118, sitting on
the bottom of the binding cleft, and Phe206 are probably
involved in a stacking interaction with a glycosyl moiety in the
+1 subsite (Sulzenbacher et al., 1999). The invariant Pro129 is
tightly sandwiched between the aromatic rings of Trp120 and
Trp147 in the middle of the `cord' region. It has been
suggested that the cord loop may undergo conformational
changes upon substrate binding, with conformational ¯ex-
ibility accompanied by a prolyl cis±trans isomerization
(Torronen et al., 1994; Sulzenbacher et al., 1999). It is
presumed that the cord movement upon ligand binding facil-
itates the interaction of the conserved Trp120 and Trp147 with
the hydrophobic faces of the oligosaccharide ligand in subsites
+2 and +3, respectively.
Family 12 enzymes perform catalysis with net retention of
anomeric con®guration. The mechanism is widely held to be a
double-displacement reaction in which a covalent glycosyl-
enzyme intermediate is formed and subsequently hydrolyzed
via an oxocarbonium-ion-like transition state (Koshland, 1953;
Davies et al., 1998). Enzymological (Zechel et al., 1998) and
structural (Sulzenbacher et al., 1999) studies of CelB2
con®rmed the role of Glu120 and Glu203 as the catalytic
nucleophile and the general acid/base, respectively. Glu120
and Glu203 in CelB2 correspond to Glu116 and Glu204 in
EglA, respectively.
Asp99, which is conserved in family 12, is 2.6 AÊ from the
nucleophile Glu112. This residue would not only help to
maintain an appropriate charge on the nucleophile during the
catalytic cycle, but would also hold Glu116 in a favorable
orientation for nucleophilic attack. Asp95 is 2.6 AÊ from the
catalytic acid/base residue Glu204. This residue, which is
conserved or substituted by aspargine in other family 12
enzymes, may have a role in appropriate charge maintenance
of catalytic acid/base residues during the enzymatic reaction.
3.4. Structural comparison of EglA with CelB2 and xylanase
The sequence identity between CelB2 (Sulzenbacher et al.,
1997) and EglA is relatively low at 26% (Fig. 1). Superposition
of the re®ned structure of EglA and CelB2 (PDB code 1nlr)
using the SPOCK program package (Christopher, 1998)
resulted in an r.m.s.d. of 1.17 AÊ for 159 equivalent C posi-
tions limited to core regions. This three-dimensional compar-
ison shows that the core regions (-sheets A and B) are
similar, whereas signi®cant differences are observed in the
surface-loop regions (Fig. 4a). The long loop between strands
B3 and A5 in CelB2 contains both a 310-helix and two addi-
tional short -strands (-sheet C). These two short -strands,
together with the two loops between strands B5 and B6 and
strands B7 and B8, make up one rim of the active-site cleft in
CelB2. The residues His65 and Tyr66 in -sheet C interact
with the glucopyranose ring in subsites ÿ2 and ÿ3 (Sulzen-
bacher et al., 1999). However, these two short -strands do not
exist in the EglA structure and thus -sheet C of CelB2 is not
conserved in all members of family 12. During preparation of
this manuscript, the 1.9 AÊ resolution structure of a -1,4-
endoglucanase from Trichoderma reesei (Cel12A) was deter-
mined (Sandgren et al., 2001) and is similar to the native
structure described here. Cel12A also lacks -sheet C. Since
EglA does not possess -sheet C, the active-site cleft is also
open at the non-reducing end. Asn63 from -strand B3 in
EglA, corresponding to Tyr66 in CelB2, would interact with
substrate in the subsite ÿ3.
Although the sequence similarity between families 11 and
12 is extremely low, hydrophobic cluster analysis indicates that
the structures would have the same overall fold (Torronen et
al., 1993). On the basis of sequence analysis, families 11 and 12
were proposed to be a single clan, GH-C. Superposition of
EglA and xylanase II, XYNII, from T. reesei (PDB entry 1enx)
Figure 3
The binding-cleft environment of EglA. The electron-density map
(2Fo ÿ Fc) for the catalytic residues Glu116 and Glu204 is contoured at
2.0. The six putative subsites (from subsiteÿ3 through +3) are shown by
vertical arrows.
indicated an r.m.s.d. of 2.36 AÊ for 122
equivalent C positions in the core region of
two proteins (Fig. 4b). There is 16% identity
between the sequences of EglA and XYNII.
Signi®cant differences are found at the
surface-loop regions. While XYNII lacks the
putative -strand A1, there is a short A1
strand in EglA. XYNII, like EglA, lacks the
two short -strands between strands B3 and
A5 (-sheet C). Therefore, the non-reducing
end of the binding cleft of XYNII, like EglA
and Cel12A, is open.
3.5. Structure of palladium±EglA complex
Addition of 100 mM PdCl2 to 1 mg ml
ÿ1
EglA inhibits more than 94% of enzyme
activity against 1% carboxymethyl cellulose
(CMC) (Fig. 5). The inhibition of EglA by
palladium is irreversible based on the
following ®ndings. When 100 mM PdCl2 is
incubated with 5 mM EDTA for 15 min
before addition of EglA, no inhibition of
EglA will occur. This shows that EDTA
chelates with Pd2+ and subsequently
prevents Pd2+ from inhibiting EglA.
However, if 5 mM EDTA is added 10 min
after the start of reaction between EglA and
CMC in the presence of 100 mM PdCl2,
there is no reversal of inhibition even after
60 min of reaction time. Apparently, in this
condition Pd2+ binds irreversibly to EglA and addition of
EDTA does not remove Pd2+ from its binding site. EDTA by
itself does not have any effect on the activity of the EglA.
Furthermore, platinum, mercury or lead complexes did not
show an inhibitory effect on the enzyme.
The structure of the palladium±EglA complex shows that
three Pd2+ ions bind to each molecule of EglA (Fig. 6a).
Superposition of the C atoms of the native EglA and palla-
dium±EglA complexes shows an r.m.s.d. of 0.4 AÊ . Therefore,
inactivation of EglA by palladium does not arise from
conformational changes in the backbone of the enzyme.
A Pd2+ ion binds to the active site of EglA by forming a
coordinate covalent bond with Met118 S (Fig. 6b). The bond
length is almost 2.2 AÊ , which is consistent with bond lengths
between Pd2+ and thioether atoms in other organometallic
compounds (Battaglia et al., 1973; McCrindle et al., 1982).
Met118, which is conserved in all members of family 12,
resides on the bottom of the binding cleft and its side chain is
located between the general acid/base (Glu204) and the
catalytic nucleophile residue (Glu116) involved in a stacking
interaction with a glycosyl moiety in the +1 subsite (Sulzen-
bacher et al., 1999). This Pd2+ ion forms another coordinate
covalent bond with the nucleophilic Glu116 O"1 (2.4 AÊ bond
length). It seems that Met118 is necessary for the binding of
Pd2+ to EglA. However, for inactivation of the enzyme,
binding to the nucleophilic glutamate is important. The
complex between Pd2+ and EglA is a -bonded organopalla-
dium (II) complex, as found in many organopalladium
complexes. We could not detect any other ligand involved in
coordination. This ®nding is consistent with previous
assumption that PdCl2 binds to the endoglucanase as a free
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Figure 5
The inhibitory effect of PdCl2 on EglA. Solutions of 1 mg ml
ÿ1 EglA
(1 mg mlÿ1) were incubated with 0, 1, 10, 100 and 200 mM PdCl2 for 15 min
at room temperature. The enzyme activity was determined against 1%
carboxymethyl cellulose (CMC).
Figure 4
Stereoview of the superposition of EglA with (a) CelB2 from S. lividans and (b) XYNII from
T. reesei. EglA is in blue, CelB2 is in purple and XYNII is in green.
research papers
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Pd2+ ion (Lassig et al., 1995). In addition to those coordinate
covalent bonds, Pd2+ makes non-bonded interactions with
Glu116 O"2 (2.9 AÊ ) and with the catalytic acid/base residue
Glu204 O"1 (3.2 AÊ ). Based on these results, one can
conclude that the coordinate covalent binding of Pd2+ to
Met118 S and Glu116 O"1 blocks the active site and inacti-
vates the enzyme.
The second Pd2+ ion forms a coordinate covalent bond with
His46 N"2 on the surface of the protein (Fig. 6c). Since His46 is
far from the active site of the enzyme, binding of palladium to
this site does not have any inhibitory effect on the enzyme.
These results are consistent with the previous kinetics results
showing that palladium most likely forms a covalent bond with
the imidazole N atom of His206 or His228 of CBH I, but that
this binding does not play any signi®cant role in the inhibition
of CBH I by palladium (Lassig et al., 1995). This palladium ion
makes an electrostatic interaction with the phenyl ring
-electrons of Tyr34, which is about 2.6 AÊ from the Pd2+ ion.
The third Pd2+ ion forms coordinate covalent bonds with
Val33 N (Fig. 6d). This palladium ion is close to the only
disul®de bond in EglA between Cys4 and Cys32 (the distance
between the Pd2+ ion and Cys4 S is 3.3 AÊ ). Lassig et al.
(1995) proposed that inactivation of CBH I by palladium is a
consequence of the cleavage of disul®de bonds. However, our
structural studies of the EglA±palladium complex show that
the disul®de bond between Cys4 and Cys32 has not been
cleaved, although the palladium-binding site is close to this
disul®de bond.
The results of this study establish the mode of inhibition of
EglA by palladium complexes. However, inhibition of other
cellulases by palladium complexes may follow alternative
mechanisms. Cellobiohydrolase I (CBH I) and endoglucanase
II (EG II) from T. reesei, which are also inhibited by palladium
complexes, belong to family 7 and family 5, respectively. These
two enzymes do not have methionine in their active sites;
therefore, the mechanism of inhibition in these two enzymes
Figure 6
(a) The structure of EglA complexed with three Pd2+ ions, B, C and D. (b), (c) and (d) The binding site for Pd2+ ions B, C and D, respectively. The
electron-density maps (Fo ÿ Fc) for the three Pd2+ ions are contoured at 7.0. The Pd2+ ions are in green.
should be different from that of EglA. Structural elucidation
of other cellulase±palladium complexes will show the
mechanism of their inactivation by palladium complexes.
The structure of the palladium±EglA complex now adds a
new dimension to efforts aimed towards designing novel
inhibitors in order to control cellulase activity in the fungus
A. niger which deteriorates cellulose-based materials (Reese,
1974).
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